Member Exclusive News

The week in industry: Canada approves its first ever RNAi therapeutic

This week: Orphan Status granted for Muscular Atrophy treatment, The AMR Centre and Shionogi join forces to further develop antiviral treatment and Takeda extends option to develop Humabody therapies.

Jul 25, 2019

Please sign in or register for FREE

No comments yet.